Literature DB >> 12671073

IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory.

Patrick R Burkett1, Rima Koka, Marcia Chien, Sophia Chai, Faye Chan, Averil Ma, David L Boone.   

Abstract

The generation and maintenance of immunological memory requires the activation, expansion, and persistent proliferation of antigen-specific T cells. Recent work suggests that IL-15 may be important for this process. Surprisingly, we now find that expression of the high-affinity receptor for IL-15, IL-15R alpha, on T cells is dispensable for the generation or maintenance of memory CD8(+) T cells. By contrast, IL-15R alpha expression on cells other than T cells is absolutely critical for this function. These findings may be related to IL-15R alpha's ability to present IL-15 in trans to low-affinity IL-15R beta gamma(c) receptors on memory CD8(+) T cells. These unexpected results provide insights into how IL-15R alpha supports memory CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671073      PMCID: PMC153623          DOI: 10.1073/pnas.0737048100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Preferential localization of effector memory cells in nonlymphoid tissue.

Authors:  D Masopust; V Vezys; A L Marzo; L Lefrançois
Journal:  Science       Date:  2001-03-01       Impact factor: 47.728

2.  Visualizing the generation of memory CD4 T cells in the whole body.

Authors:  R L Reinhardt; A Khoruts; R Merica; T Zell; M K Jenkins
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.

Authors:  N Manjunath; P Shankar; J Wan; W Weninger; M A Crowley; K Hieshima; T A Springer; X Fan; H Shen; J Lieberman; U H von Andrian
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Persistence of memory CD8 T cells in MHC class I-deficient mice.

Authors:  K Murali-Krishna; L L Lau; S Sambhara; F Lemonnier; J Altman; R Ahmed
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

5.  IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.

Authors:  F Mattei; G Schiavoni; F Belardelli; D F Tough
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Control of homeostasis of CD8+ memory T cells by opposing cytokines.

Authors:  C C Ku; M Murakami; A Sakamoto; J Kappler; P Marrack
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

7.  Interleukin-2-deficient mice develop colitis in the absence of CD28 costimulation.

Authors:  David L Boone; Themistocles Dassopoulos; James P Lodolce; Sophia Chai; Marcia Chien; Averil Ma
Journal:  Inflamm Bowel Dis       Date:  2002-01       Impact factor: 5.325

8.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.

Authors:  J P Lodolce; D L Boone; S Chai; R E Swain; T Dassopoulos; S Trettin; A Ma
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

9.  Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

Authors:  T A Fehniger; K Suzuki; A Ponnappan; J B VanDeusen; M A Cooper; S M Florea; A G Freud; M L Robinson; J Durbin; M A Caligiuri
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

10.  T cell-independent interleukin 15Ralpha signals are required for bystander proliferation.

Authors:  J P Lodolce; P R Burkett; D L Boone; M Chien; A Ma
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  51 in total

Review 1.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

Authors:  SangKon Oh; Liyanage P Perera; Donald S Burke; Thomas A Waldmann; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

3.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.

Authors:  Mark P Rubinstein; Marek Kovar; Jared F Purton; Jae-Ho Cho; Onur Boyman; Charles D Surh; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

4.  Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine.

Authors:  Cary Hsu; Marybeth S Hughes; Zhili Zheng; Regina B Bray; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  Survival adjustment of mature dendritic cells by IL-15.

Authors:  Sigrid P Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

6.  Latent virus influences the generation and maintenance of CD8+ T cell memory.

Authors:  Brian S Sheridan; Kamal M Khanna; Gregory M Frank; Robert L Hendricks
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

7.  CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.

Authors:  Yuwen Zhu; Gefeng Zhu; Liqun Luo; Andrew S Flies; Lieping Chen
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

8.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Authors:  Thomas A Stoklasek; Kimberly S Schluns; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

9.  Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation.

Authors:  Spencer W Stonier; Lisa J Ma; Eliseo F Castillo; Kimberly S Schluns
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

10.  Safety and immunologic effects of IL-15 administration in nonhuman primates.

Authors:  Carolina Berger; Michael Berger; Robert C Hackman; Michael Gough; Carole Elliott; Michael C Jensen; Stanley R Riddell
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.